Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
出版年份 2016 全文链接
标题
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
作者
关键词
Regulatory T cells, T cells, Blood, Lymphocytes, Eosinophils, Blood counts, Blood plasma, Cloning
出版物
PLOS MEDICINE
Volume 13, Issue 10, Pages e1002139
出版商
Public Library of Science (PLoS)
发表日期
2016-10-12
DOI
10.1371/journal.pmed.1002139
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes
- (2015) Jennie H.M. Yang et al. DIABETES
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
- (2015) Kellee M. Miller et al. DIABETES CARE
- Low levels of C-peptide have clinical significance for established Type 1 diabetes
- (2015) W. M. Kuhtreiber et al. DIABETIC MEDICINE
- Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
- (2015) J. A. McKnight et al. DIABETIC MEDICINE
- IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients
- (2015) Ricardo C. Ferreira et al. DIABETOLOGIA
- Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing
- (2015) Daniel B. Rainbow et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells
- (2015) Charles J.M. Bell et al. JOURNAL OF AUTOIMMUNITY
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune homeostasis enforced by co-localized effector and regulatory T cells
- (2015) Zhiduo Liu et al. NATURE
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
- (2015) Judy H Cho et al. NATURE MEDICINE
- Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)
- (2015) James Heywood et al. Trials
- Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
- (2015) Lucy A Truman et al. BMJ Open
- Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes
- (2014) W. S. Thompson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Follicular helper T cell signature in type 1 diabetes
- (2014) Rupert Kenefeck et al. JOURNAL OF CLINICAL INVESTIGATION
- Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
- (2014) Sawa Ito et al. MOLECULAR THERAPY
- Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
- (2014) F. Waldron-Lynch et al. BMJ Open
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- IL-2 therapy in type 1 diabetes: “Trials” and tribulations
- (2013) S. Alice Long et al. CLINICAL IMMUNOLOGY
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients
- (2013) Kate Downes et al. DIABETOLOGIA
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
- (2013) Geok Choo Sim et al. JOURNAL OF CLINICAL INVESTIGATION
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Immune therapy in type 1 diabetes mellitus
- (2013) Åke Lernmark et al. Nature Reviews Endocrinology
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
- (2012) T. Duhen et al. BLOOD
- Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
- (2012) K. C. Herold et al. DIABETOLOGIA
- Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function
- (2012) G. Garg et al. JOURNAL OF IMMUNOLOGY
- Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
- (2012) F. Waldron-Lynch et al. Science Translational Medicine
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic medicine: Novel strategies for clinical trials
- (2010) Andrea A. Itano et al. AUTOIMMUNITY
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
- (2010) Yenkel Grinberg-Bleyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource
- (2009) Calliope A Dendrou et al. NATURE GENETICS
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started